FDA approves Steglatro from Merck and Pfizer for Type II diabetes

FDA approved Steglatro ertugliflozin from Merck & Co. Inc. (NYSE:MRK) and Pfizer Inc. (NYSE:PFE) as an adjunct to diet and exercise

Read the full 215 word article

User Sign In